Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 1;24(5):293-299.
doi: 10.1097/ACI.0000000000001012. Epub 2024 Jul 24.

Tryptase in drug-induced anaphylaxis: the need for acute and baseline values

Affiliations
Review

Tryptase in drug-induced anaphylaxis: the need for acute and baseline values

Moïse Michel et al. Curr Opin Allergy Clin Immunol. .

Abstract

Purpose of review: The purpose of this narrative review was to summarize data and official recommendations purporting to paired tryptase determination in patients experiencing drug-induced anaphylaxis, published between January 1, 2023 and June 1, 2024.

Recent findings: Three main lines of evidence obtained through paired acute and baseline tryptase determination were identified: diagnostic criterion for hypersensitivity reactions involving systemic mast cell activation; differential diagnostic criterion for hypersensitivity reactions involving other mechanisms of immediate reactions; and added value of acute and baseline tryptase levels for personalized management following drug-induced anaphylaxis: cause, risk of recurrence, underlying mast cell conditions including hereditary α-tryptasemia, familial clusters.

Summary: The implementation of existing guidelines which consensually recommend paired tryptase measurement is a persistent unmet need hampering optimal diagnosis of drug-induced anaphylaxis and patient management. Another major unmet need is the lack of standardized recommendations for hereditary α-tryptasemia testing and counselling. Progress in this field is seen at a rapid pace, requiring significant efforts of continued medical education for practicing clinicians and laboratory specialists worldwide.

PubMed Disclaimer

References

    1. Hofer V, Dolle-Bierke S, Francuzik W, et al. Fatal and near-fatal anaphylaxis: data from the European Anaphylaxis Registry and National Health Statistics. J Allergy Clin Immunol Pract 2024; 12:96–105. e108.
    1. Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: A 2023 practice parameter update. Ann Allergy Asthma Immunol 2024; 132:124–176.
    1. Pouessel G, Tacquard C, Tanno LK, et al. Anaphylaxis mortality in the perioperative setting: epidemiology, elicitors, risk factors and knowledge gaps. Clin Exp Allergy 2024; 54:11–20.
    1. Muraro A, Worm M, Alviani C, et al. EAACI guidelines: anaphylaxis (2021 update). Allergy 2022; 77:357–377.
    1. Alvarez-Arango S, Kumar M, Chow TG, Sabato V. Non-IgE-mediated immediate drug-induced hypersensitivity reactions. J Allergy Clin Immunol Pract 2024; 12:1109–1119.